Kraiczy, Peter <br/><br/>
Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.  [electronic resource] 

 -  Journal of medical microbiology  Oct 2000 
 - 917-928 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2615 
<br/><br/><label>Standard No.: </label>10.1099/0022-1317-49-10-917  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Antibodies, Monoclonal<br/>Antigens, Bacterial<br/>Bacterial Outer Membrane Proteins--chemistry<br/>Borrelia--growth & development<br/>Complement C3--immunology<br/>Complement C6--immunology<br/>Complement C9--immunology<br/>Complement System Proteins--immunology<br/>DNA Primers--chemistry<br/>DNA, Bacterial--chemistry<br/>Electrophoresis, Polyacrylamide Gel<br/>Enzyme-Linked Immunosorbent Assay<br/>Flagellin--chemistry<br/>Fluorescent Antibody Technique, Indirect<br/>Humans<br/>Immune Sera--immunology<br/>Immunoblotting<br/>Lyme Disease--blood<br/>Microscopy, Electron<br/>Microscopy, Immunoelectron<br/>RNA, Bacterial--chemistry<br/>Reverse Transcriptase Polymerase Chain Reaction